Gyre Therapeutics, Inc. GYRE US Equity☆

Gyre Therapeutics, Inc. (Nasdaq: GYRE), an SEC filer in Pharmaceutical Preparations, closed at $6.59, -1.3%, on 2026-08-28, with a market cap of $745M as of 2026-08-27, a trailing P/E of 334.0, a return on equity of 11.7%, a net margin of 8.5% and 3-year sales growth of 4.5%. Institutional ownership, earnings history and filed financials are on the tabs below.